On December 13, 2019 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, reported that it will hold a conference call on December 17, 2019 at 1:30 p.m. Pacific / 4:30 p.m. Eastern to discuss the progress made and the future plans for its CchekTM artificial intelligence based cancer diagnostic test and its CAR-T based ovarian cancer therapeutic and breast cancer vaccine programs (Press release, Anixa Biosciences, DEC 13, 2019, https://ir.anixa.com/news/detail/941/anixa-biosciences-to-host-conference-call-to-discuss-plans-for-2020 [SID1234552347]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call Information:
Interested participants and investors may access the conference call by dialing:

(877) 876-9174
Conference ID: Anixa
An audio webcast will be accessible via the Investors section of the Anixa website at View Source An archive of the webcast will remain available for 30 days after the call.